Skip to main content

FDA recall, , High risk

Automated Impella Controller (AIC)

The Automated Impella Controller has a potential software error when used with left ventricular Impella devices.

What happened

Abiomed, Inc. of Danvers, Massachusetts is recalling the Automated Impella Controller (AIC) for use with left heart support blood pumps due to a potential software error when used with left ventricular Impella devices. The recall, which began on May 14, 2026, affects 10,297 units distributed worldwide, including the US and numerous other countries. The FDA added the recall to its Enforcement Report and classified it on June 12, 2026, with the weekly enforcement report on June 24, 2026.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the list below, then check the codes the FDA notice also names.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Automated Impella Controller (AIC), for use with left heart support blood pump.

    UDI-DI
    • 00813502010886
    • 00813502011272
    • 00813502011289
    • 00813502011418
    • 00813502010428
    • 00813502011296
    • 00813502010022
    • 00813502010930
    • 00813502010961
    • 00813502011425
    • 00813502010978
    • 00813502010985
    • 00813502012958
    • 00813502012217
    • 00813502011814
    • 00813502012972
    • 00813502012484
    • 00813502011401
    Affected units
    All products below with software versions 6

Recall details

Company began the recall
Sold in

Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Brazil, Brunei, Canada, China, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, India, Ireland, Israel, Italy, Japan, Kuwait, Luxembourg, Malaysia, Mexico, Netherlands, New Zealand, Norway, Panama, Poland, Saudi Arabia, Serbia, Singapore, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Arab Emirates, United Kingdom.

Company
Abiomed, Inc.Danvers, Massachusetts
Risk

High risk

There is a reasonable chance that using it could cause serious health problems or death.

FDA Class I recall · How risk is rated

Event ID
98853
Recall number
Z-2360-2026
Quantity recalled
10,297 units

All recalls from Abiomed, Inc.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)